Introduction
Multifunctional microparticles that are simultaneously magnetic and fl uorescent have attracted interest because they can be manipulated with an external magnetic fi eld while being tracked by fl uorescence imaging in real time. [1] [2] [3] [4] [5] [6] [7] Several examples of potential uses have been demonstrated: immunoassays for bacterial spores or explosives, [ 8 , 9 ] cell-based or DNA assays, [10] [11] [12] [13] gene expression profi ling, [ 14 ] chemical sensing, [ 15 ] and safety controls of medical devices. [ 16 ] Preparation of such multifunctional microparticles generally involves incorporating the fl uorescent (organic fl uorophore, quantum dot) and magnetic (iron oxide nanoparticle) components into a non-functional matrix like silica spheres or polystyrene
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Luo Gu, Ji-Ho Park, Kim H. Duong, Erkki Ruoslahti, and Michael J. Sailor* beads. [ 1 , 2 , 7 , 13 , 17-19 ] Issues associated with this approach include quenching or leakage of the luminescent species, [ 6 , 12 , 17 , 18 ] as well as photobleaching (in the case of organic fl uorophores). [ 20 , 21 ] Although quantum dots typically display greater stability than organic dyes, toxicity of heavy-metal-containing quantum dots [ 22 ] limits their use in many biological applications. Intrinsically luminescent silicon nanostructures offer an alternative fl uorophore that can be as photostable as the conventional II-VI quantum dots, [23] [24] [25] but with lower in-vivo or in-vitro toxicity. [24] [25] [26] [27] [28] [29] Silicon is an essential trace element that is widely distributed in various mammalian (including human) tissues [ 30 , 31 ] in the form of orthosilicate (SiO 4 4 − ). Orthosilicate is the primary product of porous Si degradation in vitro and in vivo, and the low toxicity and biocompatibility of porous Si has been demonstrated. [ 32 , 33 ] Moreover, porous Si nanostructures can act as a host matrix for molecules, enzymes, proteins, magnetic nanoparticles, or other species. [34] [35] [36] [37] In this work, magnetic luminescent Si microparticles with porous nanostructures are prepared by incorporating superparamagnetic iron oxide nanoparticles into the intrinsically luminescent porous Si matrix to provide a composite that is simultaneously fl uorescent and magnetic. The anticancer drug doxorubicin is loaded into the dual-functional microparticles, and the drug is delivered to human cervical cancer (HeLa) cells in vitro under the guidance of a magnetic fi eld, demonstrating magnetic manipulation, fl uorescent tracking, and localized delivery of a molecular payload. 
Results and Discussion
Magnetic, luminescent porous Si microparticles were prepared as outlined in Figure 1a . Electrochemical etching of highly doped p-type single-crystal Si wafers in an aqueous HF solution containing ethanol produces a porous layer, which is removed from the Si substrate with a secondary current pulse. In order to activate photoluminescence, the porous Si layer is mildly oxidized in an aqueous borate buffer solution (pH = 9.2). The fi lm is then fractured by ultrasonication and fi ltered to remove fragments < 5 μ m in size. Scanning electron microscopy (SEM) reveals uniform microparticles, with an average size of 19 ± 4 μ m (n = 50, S.D.) and an average pore diameter of 21 ± 4 nm (Figure 1 b) . Fourier-transform infrared (FTIR) spectroscopy indicates that the oxidation step removes surface Si-H species from the material, generating a silicon oxide shell (Supporting Information, Figure S1 ).
The microparticles display a strong orange to near-IR photoluminescence ( Figure 2a) , which is attributed to quantum confi nement effects in the silicon cores and to Si-SiO 2 interfacial defects generated during the activation step. [ 1 , 38 , 39 ] Nitrogen adsorption/desorption measurements reveal a type IV isotherm with a pronounced hysteresis loop, indicating the nanostructure of the microparticles is mesoporous (pore diameters 2-50 nm). The specifi c surface area (BET method) and pore volume (BJH method) are 520 m 2 g − 1 and 0.712 cm 3 g − 1 , respectively (Supporting Information, Figure S2a ).
Magnetic properties were imparted to the luminescent porous Si microparticles by infusion of iron oxide nanoparticles. Superparamagnetic Fe 3 O 4 nanoparticles with mean diameters of 13 ± 2 nm (measured by transmission electron microscopy) were synthesized following a published method. [ 40 ] The nanoparticles were infused into the luminescent porous Si microparticles by placing the microparticles in an aqueous solution of iron oxide nanoparticles as described previously. [ 34 , 41 ] Once loaded, the microparticles were harvested from the suspension by centrifugation, and the iron oxide nanoparticles were trapped in the porous Si matrix by thermal oxidation/dehydration of the isolated particles in air at 100 ° C for 8 h.
The luminescent microparticles retain their overall size upon infusion of iron oxide nanoparticles. However, the average pore diameter (12 ± 3 nm), surface area (373 m 2 g − 1 ) and pore volume (0.577 cm 3 g − 1 ) are reduced compared to the iron-free microparticles ( Figure 1 c and Supporting Information, Figure S2b ). The intrinsic photoluminescence of the iron oxide-containing microparticles is similar to the ironfree microparticles, although a slight blue shift in the emission spectrum is consistently observed. This blue shift is attributed to a decrease in size of the emissive Si nanoparticles within the porous Si matrix, caused by the oxidation process (Figure 2 a) . [ 42 ] The magnetic composite materials exhibit similar photostability to other inorganic solid state nanoparticles. Like quantum dots deriving from II-VI compounds, the porous Si microparticles are signifi cantly more photostable compared with fl uorescent organic dye molecules, and they are resistant to photobleaching when exposed to UV light (Supporting Information, Figure S3 ). The quantity of iron oxide nanoparticles loaded in the porous Si microparticle carriers is 0.8% by weight (based on mass of Fe 3 O 4 , measured by inductively coupled plasmaoptical emission spectrometry, ICP-OES). Superconducting quantum interference device (SQUID) data indicates that the magnetic nanoparticles retain their superparamagnetic characteristic when incorporated in the luminescent porous Si host, with a saturation magnetization value of 0.37 emu g − 1 (based on mass of the composite microparticles, As indicated by the BET data, the microparticles still possess free open volume after loading of the iron oxide nanoparticles. This potentially allows the incorporation of an additional payload. In this work, the anticancer drug doxorubicin (DOX) was loaded as a test molecule payload, using a simple adsorption protocol. The iron oxide containing porous Si microparticles were exposed to an aqueous solution of DOX for 1 h, and the particles were harvested from the solution with the aid of a rare earth permanent magnet. The DOX molecules are suffi ciently strongly adsorbed that they are not readily removed by rinsing with pure water. However, the DOX molecules are slowly leached into a phosphate buffered saline solution over a period of several days ( Figure 3c ). Approximately 0.109 mg of DOX was loaded per milligram of magnetic luminescent porous Si microparticles (9.8% by mass). Based on the measured (BET) surface area, the theoretical percent loading of a monolayer of DOX, is 4.4%, which is signifi cantly smaller than the experimental result. The larger loading of DOX measured experimentally represents multilayer adsorption, attributed to electrostatic interactions between the positively charged DOX molecules and the negatively charged silicon oxide pore walls, and self-association via π -π stacking interactions between DOX molecules. [ 43 , 44 ] It has been reported that freshly etched porous Si (H-terminated) is a strong reducing agent that can react with molecular drugs such as DOX. [ 45 ] Therefore, UV-Vis spectroscopy and highperformance liquid chromatography-mass spectrometry (HPLC-MS) were performed to determine if the chemical composition and the structure of the DOX molecules loaded into the magnetic luminescent porous Si microparticles remain intact. The UV-Vis absorption spectrum of DOX extracted from the porous Si microparticles is identical with the DOX standard (Supporting Information, Figure S4 ). In addition, DOX extracted from the porous Si microparticles displays a single peak in the HPLC trace, with a retention time identical to that of the DOX standard (Figure 3 a) . Finally, mass spectrometry yields a spectrum identical to the DOX standard (Figure 3 b) , indicating that there is no signifi cant chemical reaction between DOX and the porous Si matrix in the timescale and conditions of the present study. This lack of reactivity is attributed to the fact that the microparticles used in the present study are more extensively oxidized, presenting an inert SiO 2 surface to the DOX molecules (Supporting Information, Figure S1 ).
The DOX-loaded magnetic luminescent porous Si microparticles exhibit a continuous release at physiological pH and temperature; 90% of the adsorbed drug is released in 9 days (Figure 3 c) . Fluorescence microscope images indicate degradation of the porous Si matrix during the release period (Figure 3 d) , and no particles were observable by optical microscopy after day 9 under these release conditions. The degradation and dissolution process provides a mechanism by which the mesoporous drug carrier can be eliminated once it has performed its function, and this process can be monitored through the intrinsic luminescence of the porous Si matrix.
Free radical formation by means of cellular reduction of Fe (III) has been implicated in the observed cardiotoxicity of doxorubicin. [ 46 ] Cell viability assays were performed to determine if the iron oxide nanoparticles co-loaded with DOX increase the overall cytotoxicity of the formulation. HeLa (human cervical cancer) cells were incubated with free DOX together with iron oxide nanoparticles (using the same DOX:Fe 3 O 4 ratio as that in the loaded porous Si microparticles) for 48 h, and the cell viability was evaluated by MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) assay. No signifi cant difference in cytotoxicity was observed for the experiments with or without Fe 3 O 4 nanoparticles (Supporting Information, Figure S5 ). This is attributed to the relatively small iron content in the microparticle formulations (Fe 3 O 4 :DOX mass ratio = 8:98).
The ability of the magnetic, luminescent porous Si microparticles to deliver DOX to HaLa cells in vitro under full papers magnetic guidance was assessed. HeLa cells were seeded and cultured in a 60-mm Petri dish. A 0.10 mg quantity of DOXloaded magnetic luminescent porous Si microparticles were added and attracted to one edge of the Petri dish using a rare earth permanent magnet. The Petri dish was agitated for 1 min with the magnet in place and then incubated for 24 h without agitation. After incubation, the particles were still accumulated at the edge of the Petri dish in the vicinity of the magnet, and cell death was apparent in a small region (diameter ∼ 1 cm) surrounding the particles ( Figure 4a-d) . Phase contrast microscope images obtained along a radius of the Petri dish, beginning at a spot 1 mm from the magnet location and ending at the center of the dish (Figure 4 i) , reveal the distance dependence of cell death. Few live cells, and a large quantity of light-refracting dead cells [ 47 , 48 ] are detected at the spot closest to the magnet, where the DOX-loaded microparticles are concentrated (Figure 4 a) . The ratio of live to dead cells increases further away from the edge where the microparticles are located, and the ratio increases dramatically at a distance > 10 mm from the microparticles; the center of the dish contains what appears to be only live cells (Figure 4 b-d) . The phase contrast microscopy results are supported by fl uorescence microscopy, using the fl uorogenic viability stain calcein acetoxymethylester (Calcein AM), an intracellular esterase activity probe (Figure 4 e-h) . [ 49 ] The data indicate that the porous Si microparticles can deliver and release the drug doxorubicin to kill HeLa cells, and that the effect can be localized under the infl uence of an external magnetic fi eld and reduce unintended systemic toxicity of the drug. As a control, a Petri dish containing HeLa cells was incubated with the same quantity of DOX-loaded magnetic, luminescent porous Si microparticles, but in the absence of an applied magnetic fi eld. A uniformly dispersed and relatively lower density of dead cells was observed in the Petri dish after 24 h incubation in this control experiment ( Figure 4 j and 4k) . Similarly, HeLa cells incubated with 1 μ g mL − 1 of free DOX (equal to the quantity of DOX released from 0.10 mg of microparticles within 24 h) showed dispersed cell death throughout the Petri dish, consistent with the known cytotoxicity of the drug (Supporting Information, Figure S6 ). To verify the localized death of cells was not caused by the particles themselves, drug-free magnetic, luminescent porous Si microparticles were incubated with HeLa cells under the infl uence of a magnet. No dead cells were observed and the morphology of the cells remained normal (Supporting Information, Figure S7 ). The effect of the quantity of particles on cell viability was also tested. A series of experiments employing 0.1, 0.2, and 0.4 mg of DOX-loaded microparticles were incubated in separate Petri dishes, each containing a similar quantity HeLa cells for 8 h under the infl uence of a magnetic fi eld. The quantity of dead cells was observed to increase with increasing concentration of microparticles (Supporting Information, Figure S8 ).
Conclusions
In summary, microparticles containing both fl uorescent and magnetic functions have been prepared by incorporating iron oxide nanoparticles into an intrinsically luminescent porous silicon matrix. A large quantity of doxorubicin (9.8% by mass) can be loaded into the composite microparticles, and a prolonged release of the drug is observed that is coincident with the physical degradation of the microparticulate carriers. Under the guidance of a magnetic fi eld, in vitro localized delivery of the drug to cancer cells can be achieved, which provides a strategy to decrease the systemic toxicity of molecular drugs. Moreover, the low toxicity of the silicon and iron constituents of the composite microparticles, and the ability to load very dissimilar payloads into the porous Si matrix suggest that the approach may be of use for bioassay and therapeutic applications such as regional chemotherapy for the treatment of ovarian cancer through intraperitoneal administration. 
Experimental Section
Preparation of Luminescent Porous Si Microparticles : Porous silicon samples were prepared by an anodic electrochemical etch of boron doped p-type Si wafers (0.0008-0.0012 Ω − cm resistivity, < 100 > orientation, Siltronix, inc.) in 3:1 (v:v) 48% aqueous HF:ethanol. A Tefl on etch cell that exposed 8.8 cm 2 of the polished Si wafer surface was used. Samples were etched at a constant current density of 200 mA cm − 2 for 150 s. The porous Si fi lm was then removed from the crystalline Si substrate by application of a current pulse of 4 mA cm − 2 for 250 s in a solution of 3.3% aqueous HF in ethanol. The free-standing porous Si fi lm was immersed in a sodium borate buffer solution (6.2 mg mL − 1 , pH = 9.2) for 5 min to activate the visible to near-IR emission, and it was then washed with deionized water several times. The luminescent porous Si fi lm was placed in deionized water and fractured into microparticles by ultrasonication for 5 h (FS5, Fisher Scientifi c) . The small fragments were removed by fi ltration through a 5 μ m fi lter membrane (Millipore).
Preparation of Magnetic, Luminescent Porous Si Microparticles : Superparamagnetic iron oxide (Fe 3 O 4 ) nanoparticles were synthesized following a published method. [ 40 ] The iron oxide nanoparticle suspension was diluted with 3 parts acetone to 1 part nanoparticle suspension in order to make the fi nal concentration of iron oxide ∼ 0.6 mg mL − 1 . The luminescent porous Si microparticles were then added to the iron oxide nanoparticle suspension and stirred for 5 min in air at room temperature. The particulate product was isolated from solution by centrifugation and rinsed several times with acetone and water to remove the free iron oxide nanoparticles. The porous Si/iron oxide composite was then thermally oxidized and dehydrated in air at 100 ° C overnight to further trap the iron oxide nanoparticles in the porous Si matrix.
Characterization : Scanning electron microscope (SEM) images were obtained using a Philips XL30 fi eld emission ESEM operating in secondary electron emission mode. N 2 adsorption isotherms (interpreted with the BET and BJH models) [ 50 ] were measured on a Micromeritics ASAP2020 analyzer. The photoluminescence spectra were obtained using a Princeton Instruments/Acton spectrometer fi tted with a liquid nitrogen-cooled silicon charge-coupled device detector ( λ ex = 370 nm and 460 nm longpass emission fi lter). The size of the iron oxide nanoparticles was characterized by transmission electron microscopy (2000EX, JEOL) and by dynamic light scattering (DLS) (Zetasizer Nano ZS90, Malvern Instruments). Magnetization data were collected using a Quantum Design MPMS2 SQUID magnetometer operating at 298 K. To quantify the amount of iron oxide contained in the composite particles, they were dissolved in hydrofl uoric acid and the iron concentration of the solution was measured by atomic emission using an inductively coupled plasma instrument fi tted with an optical emission spectrometer (ICP-OES, Optima 3000DV, Perkin Elmer). Drug loading and release : Doxorubicin (DOX) was loaded into the magnetite-containing porous Si microparticles by mixing 1 mg of particles with 0.5 mL of an aqueous solution that was 1 mg mL − 1 in DOX for 1 h in air at room termperature. The particles were harvested from the solution using a permanent rare earth magnet and rinsed 5 times with water to remove free DOX. The amount of DOX incorporated into the microparticles was determined by extracting the drug into a 1:1 water:ethanol solution 0.5 M in HCl and comparing the optical absorbance with a standard curve ( λ = 480 nm, SpectraMax Plus 384, Molecular Devices). HPLC-MS was used to compare the structure of DOX extracted from porous Si microparticles (by ethanol) and DOX standard. A Thermo LCQdeca mass spectrometer coupled with an HP1100 LC system was employed for LC-UV-MS analysis. Electrospray ionization (ESI) was used and operated under positive ion mode. The UV detection wavelength was set to monitor 480 nm. A Shiseido C-18 column (MGIII, 2.0 mm ID × 50 mm) was used for separation with a fl ow rate of 0.20 ml min − 1 . LC mobile phase A consisted of 5% methanol in water with 0.1% formic acid, and LC mobile phase B consisted of pure methanol with 0.1% formic acid. The LC gradient started from 20% B and was increased to 95% B in 18 min, then reduced to 20% B in 2 min, and then held at 20% B for 3 min. An Xcalibur 1.2 system was used for data acquisition and processing. The release of adsorbed DOX into aqueous buffer solution was studied by incubating 0.2 mg of DOX-loaded magnetic, luminescent porous Si microparticles in 1 mL of phosphate buffered saline (PBS) at 37 ° C, with the solution replaced daily. At each time point, the particles were isolated from the aqueous phase by centrifugation, and the optical absorbance of the supernatant was measured to determine the amount of released DOX. Because DOX is moderately unstable full papers under physiological conditions, [ 45 , 51 , 52 ] the stability and degradation profi le of free DOX in PBS under the above release conditions was determined by monitoring its optical absorbance. The drug release data were corrected using the degradation profi le at each time point. Fluorescence microscopy images of the DOX-loaded microparticles were acquired using a fl uorescence microscope (Eclipse LV150, Nikon) fi tted with a thermoelectrically cooled CCD camera (CoolSNAP HQ 2 , Photometrics), using an excitation wavelength of 360 nm and an emission fi lter with a bandpass at 720 ± 80 nm. Localized delivery of DOX to HeLa cells : HeLa cells were seeded into 60-mm Petri dishes with 4 mL of cell media and cultured for 2 days (the cell confl uency was ∼ 90%). The DOX-loaded magnetic luminescent porous Si microparticles (0.1 mg to 0.4 mg, depending on the experiment) were then added and attracted to an edge of the Petri dish with a rare-earth permanent magnet. The Petri dish was agitated for 1 min with the magnet attached and then incubated at 37 ° C for 8 or 24 hours without any agitation. A comparison of non-guided DOX delivery was conducted by incubating 0.1 mg of DOX-loaded magnetic luminescent porous Si microparticles with HeLa cells using the procedure described above but without the use of a magnet. Cell viability was examined by observing morphology of the cells using a phase contrast microscope (TE 300, Nikon) and by a fl uorescent viability stain assay (Calcein AM, Invitrogen, Inc.).
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